Food Noise
60 articles on Food Noise, researched and written by the Shotlee Editorial Team from primary sources.
I Lost 5 Stone on Mounjaro — But Now I’ve Had Enough
Natalie Lavergne transformed her health and lost 5 stone using Mounjaro, but now plans to switch to the Wegovy pill. Discover the medical realities of stopping weight loss medication.
8 min read
Why I Lost Virtually No Weight on Wegovy and Mounjaro
Explore the real-world experience of a patient who spent thousands on GLP-1 injections without significant results, and learn what worked instead.
7 min read
Bitter Hops Extract Supplement for Weight Loss
A recent study suggests a bitter hops extract supplement, Amarasate, could aid fat loss and preserve muscle mass, offering a potential alternative or complementary approach to GLP-1 medications.
8 min read
Ozempic Lowers Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
A new 60-week clinical trial reveals that semaglutide continues to reduce calorie consumption significantly, even when subjective hunger sensations return to baseline levels.
7 min read
The Most Confronting Side Effect of Wegovy Weight Loss Wasn't Physical
While physical side effects of Wegovy are well-documented, one patient's experience highlights a profound, non-physical challenge: the shift in how society perceives and treats individuals after significant weight loss.
7 min read
Rosie O'Donnell: Mounjaro Changed My Life After Losing 30kg
Talk show host Rosie O'Donnell discusses her 30kg weight loss using Mounjaro, the subsequent skin concerns, and the mental health benefits of GLP-1 therapy.
6 min read
Rosie O'Donnell: Mounjaro Changed My Life After Losing 30kg
Talk show host Rosie O'Donnell shares her candid experience with Mounjaro, detailing her 30kg weight loss, Type 2 diabetes management, and the physical consequences of rapid fat loss.
12 min read
Yes, GLP-1s Make You Thinner. But Do They Make You Freer?
While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.
8 min read
GLP-1 Weight-Loss Drugs Linked to Lower Risks of Addiction and Overdose
Explore the groundbreaking research linking GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Zepbound, to a reduced risk of substance use disorders and fewer addiction-related emergencies.
8 min read
Mounjaro's Impact on Food Cravings: A Case Study
A groundbreaking case study involving deep brain activity recordings has shed light on how tirzepatide, known as Mounjaro and Zepbound, impacts the brain's reward center and its connection to food cravings and loss of control eating.
8 min read
Wegovy and the Wedding Dress: The Hidden Costs of Rapid Weight Loss
Prescription weight loss drugs are becoming a wedding staple, but medical experts warn of serious side effects and ethical concerns behind the trend.
9 min read
Beyond the Pen: Navigating Weight Loss & Societal Pressures with GLP-1s
Discover how GLP-1 medications are transforming lives, offering significant weight loss and improved self-esteem. This article delves into the personal victories and the broader societal implications, including the persistent pressures on women's bodies.
8 min read
Silencing the Inner Critic: Mastering Food Noise Beyond GLP-1s
The phenomenon of 'food noise'—the constant internal monologue about what, when, and how much to eat—has become a central topic in the age of powerful weight management medications. While GLP-1 agonists are highly effective at dampening this chatter, lasting control often requires integrating behavioral and nutritional strategies. This article explores what food noise is, how medications impact it, and provides a comprehensive guide to regaining mental freedom over your eating habits.
7 min read
Ozempic, Wegovy, Mounjaro: How Long Do GLP-1s Stay in Your System?
Curious about how long Ozempic, Wegovy, Mounjaro, or other GLP-1 medications stay in your system after your last dose? This comprehensive guide explores the science behind their elimination and what factors influence their duration.
7 min read
Beyond Hunger: GLP-1s Reveal New Insights into Compulsive Behaviors
Originally developed for diabetes, GLP-1 medications are now revealing profound insights into the neurobiology of desire, reward, and compulsion, impacting everything from food cravings to addictive tendencies.
8 min read
GLP-1 Revolution in India: Affordability Meets Accessibility in Obesity Fight
The advent of affordable, locally produced GLP-1 agonists in India marks a significant shift in managing the nation's escalating obesity crisis. For millions like Manoj, these once exclusive medications are now within reach, provided they adhere to strict medical guidance and lifestyle adjustments.
6 min read
Wegovy, Mounjaro & Your Libido: How GLP-1s Reshape Desire
GLP-1 medications have transformed weight management and diabetes care, but their effects extend beyond the scale. Many users report surprising changes to their libido and sexual function. This article delves into why these powerful drugs can either boost or dampen your sex drive, offering insights from leading medical experts.
9 min read
Beyond Appetite: How GLP-1 Drugs May Be Rewiring the Human Brain
GLP-1 receptor agonists, initially celebrated for revolutionizing diabetes and weight management, are now at the center of an unplanned, massive neuroscience experiment. Emerging data suggests these powerful medications are doing more than just regulating metabolism; they appear to be structurally and functionally altering key brain systems.
7 min read
The Next Wave of Weight Loss: Understanding Oral GLP-1 Therapy
The landscape of chronic weight management is rapidly evolving beyond injectable GLP-1 medications. New research, including trials for the oral, non-peptide drug orforglipron, suggests a future where highly effective weight loss treatment is as simple as taking a daily pill, potentially overcoming barriers of cost and injection fatigue.
6 min read
Reclaiming Your Health: Beyond Weight Loss with GLP-1 Therapies
Explore the profound impact of GLP-1 medications, like semaglutide and tirzepatide, on not just weight management but also on reclaiming one's identity and overall health. Learn how these therapies can be a catalyst for significant life changes, as illustrated by personal journeys.
10 min read
Beyond Sugar: How One Doctor Lost 94 lbs & Silenced Food Noise
Dr. Stacy Smalley shares her transformative journey of losing 94 pounds by eliminating sugar, detailing how it silenced persistent cravings and improved her overall well-being. This article explores the science behind sugar's impact on appetite and provides actionable strategies for readers to achieve similar results.
8 min read
How One Woman Lost 55kg with PCOS Without Ozempic: The Role of Magnesium
Heather Marie lost 55kg managing PCOS and hypothyroidism through lifestyle and magnesium supplementation, avoiding injectables like Ozempic. Here is her story and the medical science behind it.
7 min read
Lizzo's 'Weight Release': Redefining Body Autonomy & Health Goals
Lizzo's approach to 'weight release' is more than a trend; it's a profound shift towards body autonomy, prioritizing functional health and self-defined goals over external pressures. Discover how this empowering framework can guide your own wellness journey.
7 min read
The 'Ozempic Personality': Understanding Emotional Changes with GLP-1s
While GLP-1 medications are celebrated for weight loss and reduced food noise, some users report emotional flattening. This article delves into the 'Ozempic personality' phenomenon, its potential causes, and expert perspectives on managing these psychological shifts.
7 min read
Could GLP-1 Medications Cause Anhedonia? Understanding the 'Ozempic Personality' Phenomenon
Is your GLP-1 medication affecting your mood? Discover the science behind anhedonia, the 'Ozempic personality' phenomenon, and what experts say about dopamine and metabolic health.
3 min read
Is 'Ozempic Personality' Real? Mental Health Complaints Examined
Ozempic has transformed weight loss by silencing 'food noise' for many users, but now 'Ozempic personality' is sparking debate. A report highlights mental health complaints during treatment. Is this side effect real, or just hype?
5 min read
How Layla Taylor Got GLP-1 in Utah: Eating Disorder Warning
Reality star Layla Taylor shares her concerning experience obtaining a GLP-1 prescription with alarming ease in Utah, revealing how the medication became an 'unhealthy crutch' amid her long-term battle with an eating disorder. Her story highlights critical gaps in patient screening and mental health considerations.
7 min read
Study: 10% of Wegovy and Ozempic Users See Minimal Weight Loss
Recent trials show about 10% of people using Wegovy and Ozempic experience minimal weight loss, classified as 'non-responders.' Despite average reductions of 15-20%, stories like Samantha Jess's highlight real challenges. Discover why GLP-1 drugs don't work for everyone and how to optimize results.
5 min read
1 in 10 Wegovy and Ozempic Users Lose Less Than 5% Body Weight
Trials show one in ten people on Wegovy and Ozempic lose less than 5% of their body weight, challenging the drugs' reputation as a universal solution. Patient experiences like Samantha Jess's highlight non-responder realities, while experts explain genetic and metabolic factors. Discover why GLP-1 agonists work for some but not others.
6 min read
Ozempic Turned Happy Drunk to Sad One with Horrendous Hangovers
Trey Luker-Stewart lost 60 pounds on Ozempic, but it transformed his drinking from fun nights to anxious, emotional ones with brutal hangovers. As a Dallas bar owner, he's seen a 35% drop in alcohol sales linked to GLP-1 drugs. Doctors reveal why these medications blunt alcohol's rewards and worsen next-day effects.
5 min read
When Weight-Loss Drugs Like Zepbound Don't Work
Jessica Layeux spent 15 months on Zepbound with minimal weight loss, joining 1 in 10 clinical trial non-responders who lose less than 5% body weight. Scientists are investigating genetics, hormones, and other factors behind why these popular GLP-1 drugs don't work for everyone. This guide explains the science and next steps for patients.
5 min read
Ozempic-Like Shots Curb 'Drug Noise' for Addicts: Insurance When?
GLP-1 drugs like Ozempic are silencing 'drug noise' in addicts, slashing overdoses and ER visits per a massive veterans study. Dr. Ziyad Al-Aly explains how these shots target brain reward systems. But FDA approval and insurance coverage remain years away—here's what patients need to know.
5 min read
GLP-1s Reduce Substance Addiction Risk in US Veterans: BMJ Study
An observational study in the British Medical Journal reveals GLP-1 medications like semaglutide significantly lower substance use disorder (SUD) risk in US veterans with type 2 diabetes. Compared to SGLT2 inhibitors, GLP-1s reduced new addiction risks by up to 25% and improved outcomes like 50% fewer substance-related deaths. These findings challenge traditional views on addiction and metabolic health.
5 min read
Could Ozempic and GLP-1s Help ADHD Symptoms?
People with ADHD report feeling calmer and more focused on GLP-1 drugs like Ozempic, originally for obesity and diabetes. Experts explain potential links to dopamine and reduced food cravings, but stress no clinical trials prove direct benefits. Find out the real story behind social media buzz and what to discuss with your doctor.
5 min read
Study: GLP-1 Drugs May Fight Addiction Across Major Substances
Patients on GLP-1 drugs like Ozempic report losing interest in cigarettes, alcohol, and more without effort. A physician-led study of over 600,000 VA patients reveals these medications cut addiction-related deaths by 50% and prevent new substance use disorders. This could transform treatment for alcohol, opioids, cocaine, cannabis, and nicotine.
5 min read
Man Loses 6 Stone on Mounjaro, Warns of 'Horrible' Side Effects
A man who shed six stone on Mounjaro shares his dramatic transformation from 123kg, but warns of 'horrible' side effects like chronic vomiting and dehydration no one mentioned. Despite the challenges, he reduced hypertension meds and gained food control. Discover his full story and management strategies.
5 min read
GLP-1s Curb Cravings Beyond Food: 600K Study Suggests
Patients on GLP-1 drugs report losing cravings not just for food, but for cigarettes, alcohol, and more—without effort. A new study of over 600,000 people confirms dramatic reductions in overdoses, deaths, and new addictions. Could semaglutide and tirzepatide redefine addiction care?
5 min read
Nutrition & Lifestyle Guidance for GLP-1 Medications with Dietician Diana Reid
Following up on real mom experiences with GLP-1 medications, dietician Diana Reid reveals the hidden pitfalls beyond the 'magic wand' hype. From the beach ball metaphor for body set points to essential protein and strength training, learn how to support your body properly. This balanced guide covers benefits like reduced food noise and risks like hair thinning for informed decisions.
5 min read
Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands
GLP-1 medications are reshaping bakery demands, driving growth in high-fiber, high-protein products. Ardent Mills is leading with benefit-stacking strategies using UltraGrain flour and chickpea ingredients to support satiety and digestive health for users. This guide details the research, innovations, and future outlook.
6 min read
Beyond the Scale: GLP-1 Medications' Impact on Body and Mind
Alexis Ioane hesitated before starting tirzepatide, a GLP-1 medication, but two months in, she's shed pounds, gained energy for her kids, and cleared her mind. While GLP-1s like Ozempic and Wegovy promise transformative weight loss, experts caution about mental health effects. Discover the full story on body and mind impacts.
6 min read
GP's Surprising Mounjaro Effects: Weight Loss and Mood Shifts After 3 Months
A 33-year-old GP tried Mounjaro for obesity and was stunned by more than just weight loss—his 'food noise' vanished, alcohol interest dropped, and mood stabilized. After shedding almost two stone in three months, urges returned upon stopping, highlighting obesity's chronic nature. Now back on 5mg, he emphasizes long-term strategies beyond medication.
5 min read
Leicester Doctor's Mounjaro Experience: Mental Changes & Advice
A Leicester doctor tried Mounjaro for obesity and was shocked by how it silenced his 'food noise' and curbed alcohol desires, alongside significant weight loss. But stopping brought cravings back fast. Discover his message on long-term use, side effects, and who should consider it.
5 min read
GLP-1 RAs Reduce Food Noise by 46%, Emerging Evidence Shows
Emerging evidence suggests GLP-1 receptor agonists (GLP-1 RAs) not only aid weight loss but also significantly quiet 'food noise'—those persistent, distressing thoughts about food. In the US-based INFORM survey, 550 individuals using GLP-1s reported a 46% reduction in constant food thoughts, alongside mental health gains. This could redefine obesity management for better holistic outcomes.
6 min read
Why Silencing Food Noise Requires More Than Ozempic
Food noise isn't just hunger—it's exhausting mental commentary on dieting, body image, and worthiness shaped by culture. While Ozempic and GLP-1 agonists like Wegovy promise relief, clinicians Bronwyn Wood and Courtney Nelson argue for a broader approach. Their workshops challenge weight-centric care to foster true silencing through body neutrality and informed prescribing.
6 min read
Mysterious Flat Affect Symptom in GLP-1 Users
Patients on GLP-1 medications are reporting a puzzling flat affect—not depression, but a sense of 'what's the point?' toward life goals and social plans. One doctor noticed this in three patients within a week, prompting deeper research into GLP-1s' impact on dopamine and motivation. Could this be an emerging side effect?
5 min read
New GLP-1 Weight-Loss Drugs Stronger Than Wegovy and Zepbound
When Terra Field switched from Wegovy to Zepbound, her weight loss resumed after a plateau, silencing the 'food noise' she'd battled since childhood. Now, next-generation GLP-1 drugs like CagriSema and retatrutide promise even greater results by targeting multiple gut hormones. But as these stronger treatments advance, experts caution about the risks of losing too much weight too fast.
8 min read
Lost 7st on Mounjaro: Cold Side Effect Costs £70/Month
A Liverpool mum shed 7st on Mounjaro in under a year, transforming her life—but a freezing side effect dubbed 'MJ Freeze' has spiked her energy bills by £70 a month. Emilly Murray now layers up at home with heated blankets and gloves just to stay warm. Despite the chill, she says it's worth every penny for silencing food noise and boosting her health.
5 min read
GLP-1 Equity at Work: Inclusive Strategies for All Employees
GLP-1 drugs are revolutionizing weight loss, but workplace access risks creating inequities. This guide explores the clinical science behind Ozempic, Wegovy, Mounjaro, and Zepbound, plus employer strategies for inclusive well-being. Pair meds with nutrition and support for lasting results.
4 min read
Ozempic & Mounjaro Diet: What to Eat Guide
GLP-1 medications like Ozempic and Mounjaro revolutionize weight management by curbing appetite, but pairing them with the right diet is key to lasting results. This guide reveals optimal foods, meal ideas, and strategies to combat nausea while enhancing fat loss. Discover how to eat smart on semaglutide and tirzepatide for metabolic health.
4 min read
Oprah's Ozempic Journey: GLP-1s, Strength Training & Aging
At 72, Oprah Winfrey deadlifted her way through her birthday workout, crediting GLP-1 medications like Ozempic alongside strength training for her transformation. Her candid story highlights silencing 'food noise,' the risks of weight regain, and why muscle matters in weight loss. Learn evidence-based lessons for your own journey.
5 min read
What Happens When You Stop Ozempic or Wegovy: Expert Insights
Stopping Ozempic or Wegovy often leads to significant weight regain within 1-1.5 years, reversing gains in blood sugar, pressure, and cholesterol. Experts explain the science behind this, from metabolic adaptation to surging appetite. Understand how to approach GLP-1 therapy for long-term success.
4 min read
Mounjaro Weight Regain: Why It Happens Fast & How to Fight It
Many users like the author experience devastating weight regain shortly after stopping Mounjaro, mirroring real-world and trial data. This guide unpacks the physiology, backed by studies, and offers practical steps to sustain your progress. Don't let hard-won losses slip away—arm yourself with knowledge.
5 min read
GLP-1 Drugs for Obesity: Why Treatment is Lifelong Like Oprah's Story
Oprah Winfrey shared on her podcast that stopping GLP-1 injections led to significant weight regain, sparking debate on obesity treatment. Expert insights reveal these drugs treat a chronic condition, not just temporary weight loss. Learn the science, risks, and how to approach long-term success.
4 min read
GLP-1 Revolution: Ozempic, Wegovy, Mounjaro Rise
GLP-1 injections like Ozempic, Wegovy, and Mounjaro have exploded from niche diabetes therapies to cultural icons in weight management. While offering profound metabolic benefits, their rapid mainstreaming raises questions about proper use, side effects, and societal pressures. This guide unpacks the science, real-world stories, and future implications.
4 min read
Naltrexone: Ozempic for Alcohol Cravings Explained
Naltrexone is gaining buzz as the 'Ozempic for alcohol' by blunting booze's euphoric reward, much like GLP-1 drugs curb food noise. This guide dives into its science, real-world use via the Sinclair Method, and clinical evidence for reducing intake. Learn if it's right for habitual drinkers aiming for moderation.
4 min read
Retatrutide Explained: Triple Agonist Weight Loss Drug
Retatrutide is exploding on TikTok among gym enthusiasts for its potent weight loss effects, but it's not FDA-approved yet. This guide breaks down its triple-hormone mechanism, compares it to semaglutide and tirzepatide, and warns of black market risks. Learn why experts urge caution.
4 min read
Lost 11st on Mounjaro: Simple Trick Beat Plateau
Emilly Murray transformed from 22st 2lbs to a slim 9st using Mounjaro, conquering binge eating and food noise. After hitting a plateau at 11st, she boosted water intake to 2-3 liters daily and increased meat and fish consumption. This simple strategy reignited her weight loss toward her 10st goal.
3 min read
Ozempic Era Over? BMJ Study on GLP-1 Weight Regain
The Ozempic hype may fade as a BMJ study shows users regain lost weight within 1.5 years after stopping GLP-1 drugs. These medications reduce appetite but require lifelong use and lifestyle changes for lasting results. Obesity stems from systemic issues like convenience culture and ultra-processed foods, not just willpower.
3 min read
Emilly's Mounjaro Journey: Beating Plateau for Lasting Loss
Emilly dropped from 22st to 9st 2lb on Mounjaro by tackling her plateau with more water and protein. Experts reveal why 85% of GLP-1 users stall and share proven strategies to restart progress. Avoid rapid regain by combining drugs with lifestyle changes.
3 min read
How to Beat Ozempic Plateau: GLP-1 Expert Tips
Nearly 85% of GLP-1 users hit a weight loss plateau, but experts say simple tweaks can restart progress. From optimizing doses to boosting protein and walking after meals, discover how to turbocharge Ozempic, Wegovy, or Mounjaro. Avoid quitting—stopping leads to rapid regain, per Oxford research.
4 min read